GALDERMA RECEIVES FDA APPROVAL FOR SCULPTRA® FOR CHEEK WRINKLES
/PRNewswire/ -- Galderma announced today that the U.S. Food and Drug Administration (FDA) has approved Sculptra® (injectable poly-L-lactic acid (PLLA-SCA)) for...
Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Galderma announced today that the U.S. Food and Drug Administration (FDA) has approved Sculptra® (injectable poly-L-lactic acid (PLLA-SCA)) for...
/PRNewswire/ - Apotex Corp. has expanded its oncology product portfolio with the launch of Bendamustine hydrochloride injection in the United States....
After the U.S. Supreme Court's decision to maintain access the abortion pill mifepristone, physicians will be able to keep prescribing the drug as a lower court case on its FDA approval moves through the judicial process. The appeal seeks to roll back a long-set Food and Drug Administration approval for the pill. Government lawyers have argued that the FDA followed all of the proper laws and steps in its decision-making process when the drug was approved over 20 years ago, in 2000.
Over the past 2 years, concerted efforts have been undertaken by policymakers and FDA’s Oncology Center of Excellence to mitigate risks and improve the transparency of the accelerated approval program. These actions are crucial to restoring public trust – trust that has suffered considerable erosion.
The life-saving medication is costly.